KTR inaugurates Jamp Pharma Genome Valley facility
New Delhi: Hyderabad continues to consolidate its leadership position in life sciences and Genome Valley continues to be the most preferred investment destination for companies globally, said Telangana Industries and Information Technology Minister K.T. Rama Rao.The minister on Tuesday inaugurated the facility of Jamp Pharmaceuticals Pvt. Ltd in Genome Valley here. This is the company's...
New Delhi: Hyderabad continues to consolidate its leadership position in life sciences and Genome Valley continues to be the most preferred investment destination for companies globally, said Telangana Industries and Information Technology Minister K.T. Rama Rao.
The minister on Tuesday inaugurated the facility of Jamp Pharmaceuticals Pvt. Ltd in Genome Valley here. This is the company's first facility outside Canada, and is designed to cater solid oral dosage form, powders, topicals, nasal delivery and liquid oral pharmaceutical products for regulated markets.
The facility is being established with the total investment of Rs 250 crore and total employment of around 200 people.
The minister said that he is happy to know that the leadership of Jamp Pharma systematically evaluated various locations in India and around the world and found Genome Valley to be the most attractive location for establishing their operations outside Canada.
Read also: Union Health Minister says Govt doesn't control essential medicines price
"This is indeed a testament to the overall ecosystem for life sciences in Telangana and also the pro-business policies of the Telangana government," said KTR, as the minister is popularly known.
Jamp Pharma SVP Sukhad Juneja, Principal Secretary, Industries, Jayesh Ranjan, Telangana State Industrial Infrastructure Corporation (TSIIC) VC & MD Narsimha Reddy, and Director, Life Sciences Shathi Nagappan were present.
Read also: Dr Reddys unveils Methylprednisolone Sodium Succinate for Injection in US
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd